HackerTube.dev

Peter McCullough, MD testifies to Texas Senate HHS Committee

AAPS Video · 5.3M views · 2021-03-11 · 19:33

Open on YouTube ↗

If playback is restricted in your region, try opening the original video. Use Mark watched to add it to your marked videos.

Overview

Testimony by Peter McCullough, MD, to the Texas Senate Health and Human Services Committee on March 10, 2021, about COVID-19 outpatient treatment. It was posted by the AAPS.

On Hacker News

HN commenters cite it in pandemic-era threads about early treatments and ivermectin, though the claims are contested.

Recommended by 3 HN people across 3 months · HN mentions 2021–2021

Topics

Medicine & infectious diseaseUS politics & elections
Search by tags
covid-19senate testimonyivermectinoutpatient treatmentmccullough

What people said

EricE · 2021-10 · Recommendation

lol - the only thing unproven are that the patents for drugs like ivermectin and hydroxychloroquine have expired and theres no money to be made. Isn't amazing big pharama has a new pill/non-vaccine treatment for COVID now? Funny that. The gaslighting over any treatment other than the vax is beyond criminal at this point. Just watch: [VIDEO]

Read the original HN comment ↗
EricE · 2021-10 · Recommendation

There are actually a multitude of treatments beyond waiting for thing to get bad enough that you need to go to the hospital: [LINK] This is also worth a watch: [VIDEO]

Read the original HN comment ↗
velcii · 2021-08 · Recommendation

Peter McCullough, MD testifies to Texas Senate HHS Committee The part where they talk about trials like these.. [VIDEO] Viewing full testimony is recommended.

Read the original HN comment ↗

Sources

Video by AAPS Video, played through YouTube.

Data and selection notes

HN summaries and labels may contain AI errors. HN dates refer to discussions, not video publication.

HN Library: HackerTube export (2026-10-31) and open-index/hacker-news. Upstream summaries and classifications may contain AI errors.

Views, duration and playback status refresh separately from the published catalog. When an update fails, existing data remains visible.

Selection checks
  • SaaS & AI candidates: Topic keywords do not match
  • Editor-approved picks: Editorial review is required

Rule matches identify candidates. They do not guarantee video quality or financial results.

About the library and its sources